Aemetis (NASDAQ:AMTX – Get Score) had its worth goal lower by equities researchers at Ascendiant Capital Markets to $26.00 in a analysis report issued to shoppers and buyers on Wednesday, Inventory Goal Advisor experiences. Ascendiant Capital Markets’ worth goal signifies a possible upside of 336.97% from the corporate’s present worth.
AMTX has been the subject of plenty of different experiences. Truist Monetary decreased their worth goal on shares of Aemetis to $9.00 in a analysis notice on Friday, November 4th. StockNews.com upgraded shares of Aemetis to a “promote” score in a analysis notice on Thursday, October twenty seventh.
Aemetis Inventory Efficiency
Shares of AMTX traded down $0.33 throughout mid-day buying and selling on Wednesday, reaching $5.95. The corporate had a buying and selling quantity of 10,869 shares, in comparison with its common quantity of 806,734. The corporate’s 50 day easy shifting common is $7.06 and its 200 day easy shifting common is $7.33. Aemetis has a 1-year low of $4.45 and a 1-year excessive of $20.39. The corporate has a market capitalization of $208.49 million, a price-to-earnings ratio of -2.31 and a beta of 0.83.
Institutional Traders Weigh In On Aemetis
A number of hedge funds have just lately added to or decreased their stakes within the enterprise. Allspring International Investments Holdings LLC acquired a brand new stake in Aemetis through the 1st quarter value roughly $26,000. Charles Schwab Funding Administration Inc. lifted its place in shares of Aemetis by 3.1% within the 1st quarter. Charles Schwab Funding Administration Inc. now owns 75,306 shares of the specialty chemical compounds firm’s inventory value $955,000 after buying a further 2,254 shares through the interval. JPMorgan Chase & Co. lifted its place in shares of Aemetis by 16.0% within the 1st quarter. JPMorgan Chase & Co. now owns 16,362 shares of the specialty chemical compounds firm’s inventory value $208,000 after buying a further 2,256 shares through the interval. Guggenheim Capital LLC lifted its place in shares of Aemetis by 18.7% within the third quarter. Guggenheim Capital LLC now owns 17,879 shares of the specialty chemical compounds firm’s inventory value $110,000 after buying a further 2,818 shares through the interval. Lastly, Amalgamated Financial institution acquired a brand new place in shares of Aemetis within the 1st quarter value roughly $41,000. 51.91% of the inventory is presently owned by institutional buyers and hedge funds.
About Aemetis
(Get Score)
Aemetis, Inc operates as a renewable pure gasoline and renewable fuels firm in North America and India. It operates by three segments: California Ethanol, Dairy Renewable Pure Fuel, and India Biodiesel. The corporate focuses on the acquisition, improvement, and commercialization of adverse carbon depth merchandise and applied sciences that exchange conventional petroleum-based merchandise.
See Additionally
This on the spot information alert was generated by narrative science know-how and monetary information from MarketBeat in an effort to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial staff previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.
Earlier than you contemplate Aemetis, you will wish to hear this.
MarketBeat retains observe of Wall Avenue’s top-rated and greatest performing analysis analysts and the shares they suggest to their shoppers every day. MarketBeat has recognized the 5 shares that high analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on… and Aemetis wasn’t on the checklist.
Whereas Aemetis presently has a “Average Purchase” score amongst analysts, top-rated analysts imagine these 5 shares are higher buys.
View The 5 Shares Right here
